obesity treatment with bariatric surgery vs glp-1 receptor agonists GLP1 (2025): Bariatric Surgery vs Receptor Agonists, ., ⛔️Disclaimer: This post is for educational and informational purposes only Metabolic and bariatric surgery versus
Description
Nat Med (2022) 28:5918
Schauer, D
GIP receptor activation complements the effects of GLP-1, further enhancing satiety and helping the body process and store nutrients more efficiently
Long-acting agents seem to have a lower incidence of gastrointestinal adverse effects (166), likely due to tachyphylaxis in gastric emptying with sustained GLP-1R stimulation
